Through experimental method design and clinical application, this paper investigated the detecting method and clinical significance of multi-drug resistance gene (MDR-1) expression.
本文通过实验方法研究设计和临床应用，探讨肿瘤多药耐药基因（MDR-1）的异常表达检测方法及其临床意义。
To observe the effect of Modified "Sanwubai Powder" in affecting Multidrug resistance (MDR) gene expression of tumor.
前言：观察三物白散加味方对肿瘤多药耐药(MDR)基因表达的影响。
Objective To observe the effect of Modified Sanwubai Powder in affecting Multidrug resistance (MDR) gene expression of Tumor.
目的：观察三物白散加味方对肿瘤多药耐药(MDR)基因表达的影响。
Objective To study on the expression of multiple drug resistance (MDR 1) gene during treatment course of acute leukemia (AL).
目的研究多药耐药(MDR- 1)基因在急性白血病(AL)治疗中的表达。
Objective To explore multidrug resistance (MDR) gene expression in tumor tissue of esophageal carcinoma and its application value in clinical.
目的探讨食管癌患者肿瘤组织中多药耐药(MDR)基因表达及其在临床上的应用价值。
Conclusions MDR of HCC is related to LRP expression, LRP gene expression correlates with differential degree of HCC. Detection of LRP expression could predict chemotherapy resistance of HCC.
结论HCC化疗多药耐药与其LRP表达有关，LRP表达也与HCC的分化程度有关，检测LRP表达对预测化疗耐药具有指导意义。
With appropriate designing, it could block oncogene's expression, reverse MDR, and promote tumor cell apoptosis. All these properties make the Ribozymes as potentially useful regent for gene therapy.
设计合适的核酶分子能够阻断癌基因的异常表达，逆转肿瘤细胞MDR，促进肿瘤细胞凋亡，有望成为肿瘤基因治疗的有效手段之一。
With appropriate designing, it could block oncogene's expression, reverse MDR, and promote tumor cell apoptosis. All these properties make the Ribozymes as potentially useful regent for gene therapy.
设计合适的核酶分子能够阻断癌基因的异常表达，逆转肿瘤细胞MDR，促进肿瘤细胞凋亡，有望成为肿瘤基因治疗的有效手段之一。
应用推荐